{"disease":{"id":"pancreatic-cancer-resectable","name":"pancreatic cancer resectable"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06495749","title":"Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT06670547","title":"Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Germans Trias i Pujol Hospital","has_results":false},{"nct_id":"NCT06388967","title":"Pancreatic Cancer Detection Consortium","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04596865","title":"Recurrence After Whipple's (RAW) Study","phase":"","overall_status":"COMPLETED","enrollment_count":1484,"lead_sponsor_name":"University Hospital Plymouth NHS Trust","has_results":false},{"nct_id":"NCT06073431","title":"LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT01365169","title":"Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients\"","phase":"NA","overall_status":"RECRUITING","enrollment_count":590,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07252232","title":"Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06453590","title":"Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT06944587","title":"A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT07155629","title":"Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":381,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT03590275","title":"Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX","phase":"","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Azienda Ospedaliero, Universitaria Pisana","has_results":false},{"nct_id":"NCT07529626","title":"Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":320,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT05802485","title":"PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT04736043","title":"Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03941093","title":"Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Kyntra Bio","has_results":true},{"nct_id":"NCT07081360","title":"Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":262,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT05483257","title":"Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"BAIYONG SHEN","has_results":false},{"nct_id":"NCT05524090","title":"PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":223,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT02282722","title":"Improving Informed Consent for Palliative Chemotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true},{"nct_id":"NCT04698915","title":"Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":177,"lead_sponsor_name":"Galera Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06935448","title":"Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy","phase":"","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"University of Thessaly","has_results":false},{"nct_id":"NCT07280377","title":"A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":122,"lead_sponsor_name":"Oncolytics Biotech","has_results":false},{"nct_id":"NCT02498613","title":"A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":122,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04821284","title":"Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Flemming Forsberg","has_results":false},{"nct_id":"NCT03063554","title":"EUS BD vs ERCP TP for Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05181605","title":"Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":116,"lead_sponsor_name":"Instituto de investigación e innovación biomédica de Cádiz","has_results":false},{"nct_id":"NCT03984214","title":"Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Arbeitsgemeinschaft medikamentoese Tumortherapie","has_results":false},{"nct_id":"NCT07271823","title":"Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT05802407","title":"The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06649474","title":"Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT07022015","title":"Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT06809374","title":"Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Kochi University","has_results":false},{"nct_id":"NCT06090916","title":"Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03964064","title":"I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06135896","title":"Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":98,"lead_sponsor_name":"National Cancer Center, Korea","has_results":false},{"nct_id":"NCT05265663","title":"Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06160323","title":"Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07157605","title":"Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)","phase":"","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT04986930","title":"mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":92,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04005690","title":"Targeted Pathway Inhibition in Patients With Pancreatic Cancer","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false},{"nct_id":"NCT03823144","title":"Intravital Microscopy in Human Solid Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04224402","title":"Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Yuhong Li","has_results":false},{"nct_id":"NCT06914349","title":"Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure","phase":"NA","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"University of Thessaly","has_results":false},{"nct_id":"NCT07184047","title":"Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Ankara Etlik City Hospital","has_results":false},{"nct_id":"NCT07326150","title":"Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT02595931","title":"M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":66,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06941987","title":"Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT03368963","title":"TAS102 in Combination With NAL-IRI in Advanced GI Cancers","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT06840067","title":"Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Gansu Wuwei Tumor Hospital","has_results":false},{"nct_id":"NCT02495896","title":"Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61,"lead_sponsor_name":"University of Southern California","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}